Collaboration Details

Print  Close


Title of Collaborative Activity:

Monthly Zika Vaccine Development Meeting

Description of Collaborative Activity:

This working group is collaborating on development of assays and animal models for zika vaccines. Collaboration includes exchange of study data, study reports, and regulatory strategy for assay and model development and development of a regulatory package to support licensure of products through alternative pathways.

Type of Collaborative Activity:

Resource Development

Year the Collaborative Activity Originated:

2018

NIH Participating Institutes/Centers/Office of the Director:

NIAID

HHS Agency Collaborators on this Activity:

BARDA, FDA